secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biofrontera Inc. (BFRI)
CIK:        0001858685
Form:       8-K
Filed at:   2024-01-11T23:59:59+00:00
Accession:  0001493152-24-002083
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biofrontera prelim FY2023 revenue $33.8-34.3M, record high, up ~19% YoY
-----------------------------------------------------------------------

- FY 2023 revenue $33.8M-$34.3M, record high, ~19% growth vs 2022.
- Q4 2023 revenue $10.4M-$10.9M, up ~5% vs Q4 2022.
- Second half 2023 sales grew 34%-37% compared to prior year.
- Preliminary and unaudited; final results expected in March 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858685/000149315224002083/0001493152-24-002083-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858685/000149315224002083/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-002083

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer